As of Jun 16, 2026, the Thermo Fisher Scientific stock's P/E ratio is 25.94. This takes into account the latest EPS of $18.22 and stock price of $472.63. The PE ratio has decreased by 4.7% from its last 4 quarters average of 27.2.
The PE ratio of Thermo Fisher Scientific has averaged 31.58 over the last ten years. The current price-to-earnings ratio of 25.94 is 18% less than the historical average. Analyzing the last ten years, TMO's PE ratio reached its highest point in the Sep 2024 quarter at 38.43, when the price was $614.42 and the EPS was $15.99. The lowest point was recorded in the Apr 2021 quarter, when it reached 22.78 with a price of $456.3 and an EPS of $20.03.
Maximum annual increase: 60.18% in 2013
Maximum annual decrease: -40.16% in 2011
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 32.61 | 3.92% | $579.45 | $17.77 |
| 2024 | 31.38 | -8.25% | $520.23 | $16.58 |
| 2023 | 34.2 | 10.25% | $530.79 | $15.52 |
| 2022 | 31.02 | -8.79% | $550.69 | $17.75 |
| 2021 | 34.01 | 17.48% | $667.24 | $19.62 |
| 2020 | 28.95 | -17.66% | $465.78 | $16.09 |
| 2019 | 35.16 | 14.86% | $324.87 | $9.24 |
| 2018 | 30.61 | -9.09% | $223.79 | $7.31 |
| 2017 | 33.67 | 22.17% | $189.88 | $5.64 |
| 2016 | 27.56 | -3.64% | $141.1 | $5.12 |
| 2015 | 28.6 | 8.66% | $141.85 | $4.96 |
| 2014 | 26.32 | -16.55% | $125.29 | $4.76 |
| 2013 | 31.54 | 60.18% | $111.35 | $3.53 |
| 2012 | 19.69 | 52.75% | $63.78 | $3.24 |
| 2011 | 12.89 | -40.16% | $44.97 | $3.49 |
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 25.98 | -20.33% | $473.36 | $18.22 |
| Dec 2025 | 32.61 | 21.82% | $579.45 | $17.77 |
| Sep 2025 | 26.77 | 13.58% | $464.24 | $17.34 |
| Jun 2025 | 23.57 | -19.47% | $408.28 | $17.32 |
| Mar 2025 | 29.27 | -6.72% | $500.16 | $17.09 |
| Dec 2024 | 31.38 | -18.35% | $520.23 | $16.58 |
| Sep 2024 | 38.43 | 12.37% | $614.42 | $15.99 |
| Jun 2024 | 34.2 | -7.92% | $553 | $16.17 |
| Mar 2024 | 37.14 | 8.6% | $581.21 | $15.65 |
| Dec 2023 | 34.2 | 3.64% | $530.79 | $15.52 |
| Sep 2023 | 33 | -6.88% | $506.17 | $15.34 |
| Jul 2023 | 35.44 | -5.06% | $521.75 | $14.72 |
| Apr 2023 | 37.33 | 20.34% | $576.37 | $15.44 |
| Dec 2022 | 31.02 | 9.73% | $550.69 | $17.75 |
| Oct 2022 | 28.27 | -2.28% | $507.19 | $17.94 |
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
Currently, TMO's PE ratio is under its 3, 5 and 10-year averages.
Thermo Fisher Scientific's price to earnings (P/E) of 25.94 is higher than the Healthcare sector average but lower than the industry and its peers average. Looking at the Healthcare sector average of 23.99, Thermo Fisher Scientific's price to earnings (P/E) is 8% higher.
When compared to its peers GE and ISRG, TMO's PE ratio is lower, but it is higher than A's. Thermo Fisher Scientific's PE ratio is trading below the peer average of 40.81.
| Stock name | PE ratio | Market cap |
|---|---|---|
| A Agilent Technologies Inc | 25.25 | $35.65B |
| TMO Thermo Fisher Scientific Inc | 25.58 | $173.18B |
| DHR Danaher Corp | 34.59 | $127.07B |
| BDX Becton Dickinson & Co | 35.89 | $39.07B |
| GE General Electric Co | 44.09 | $376.27B |
| WAT Waters Corp | 45.37 | $35.15B |
| ISRG Intuitive Surgical Inc | 48.39 | $143.26B |
| BIO Bio-Rad Laboratories Inc | 48.97 | $7.64B |
| TFX Teleflex Inc | N/A | $5.59B |
| BAX Baxter International Inc | N/A | $10.28B |
| BRKR Bruker Corp | N/A | $8.52B |
The price to earnings ratio for TMO stock as of Jun 16, 2026, stands at 25.94.
As an average over the last 3 years, TMO stock has a PE ratio of 31.83.
As an average over the last 5 years, TMO stock has a PE ratio of 31.11.
The highest quarterly PE ratio in the last ten years has been 38.43 and it was in the Sep 2024 quarter.
TMO's price to earnings ratio is currently 18% below its 10-year historical average.
The P/E ratio is calculated by dividing the latest price of a stock by its trailing twelve months EPS. As of today (Jun 16, 2026), Thermo Fisher Scientific's share price is $472.63. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $18.22. Therefore, Thermo Fisher Scientific's price to earnings ratio for today is 25.94. PE RATIO(25.94) = STOCK PRICE($472.63) / TTM EPS($18.22)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.